BPH, also called prostate enlargement, is a non-cancerous condition, wherein the size of the prostate increases. BPH can be treated with medication, open prostatectomy, and other invasive and minimally invasive surgical techniques. Technavio’s analysts forecast the Global Benign Prostatic Hyperplasia Devices Market to grow at a CAGR of 5.05% during the period 2018-2022.
Covered in this report The report covers the present scenario and the growth prospects of the benign prostatic hyperplasia devices market. To calculate the market size, the report considers the revenue generated from sales of benign prostatic hyperplasia devices across the globe.
The market is divided into the following segments based on geography: •Americas •APAC •EMEA
Technavio’s report, benign prostatic hyperplasia devices market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Market driver •Increasing prevalence of BPH coupled with increasing risk factors •For a full, detailed list, view our report
Market challenge •High cost of BPH treatment •For a full, detailed list, view our report
Market trend •Increasing preference for in-office based minimally invasive surgical techniques •For a full, detailed list, view our report
Key questions answered in this report • What will the market size be in 2022 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Our reports have been used by over 10K customers, including:
KEY FINDINGS The global market for viral vector vaccines is expected to grow at a CAGR of 18.19% over the forecast period of 2019-2027. Promising results from several clinical studies performed by various organizations have emphasized the potential of viral-vector-based vaccines and therapies for gene therapies. MARKET...
110 pages •
By Infiniti Research Limited
• Oct 2018
About Diffuse Large B-Cell Lymphoma DLBCL is a cancer of B-lymphocytes. It is the most common type of NHL among adults. It is an aggressive (fast-growing), complex, and difficult-to-treat form of NHL, which refers to a group of cancers of the lymphatic system. Technavio’s analysts forecast the Global DLBCL Therapeutics...
This new report is a five-country strategic analysis of major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging assays; analyzes potential applications of innovative...
This new report is a seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential...
This report provides a worldwide overview of the transfusion testing market, including estimates of facilities performing transfusion testing tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country.Contains 15 pages and 5 tables
Summary This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II,...